Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of East West Bancorp's 2026 Annual Meeting of Stockholders held on May 18, 2026. The filing presents voting results for five proposals: election of eleven directors, advisory vote on executive compensation, amendment and restatement of the 2021 Stock Incentive Plan, adoption of the 2026 Employee Stock Purchase Plan, and ratification of KPMG LLP as independent auditors. All proposals passed with substantial majorities (ranging from 95.18% to 99.92% of votes cast), and the disclosure includes detailed vote tallies for each matter as required by SEC rules.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-05-19
Item 2.02
The filing discloses a press release issued on May 15, 2026 announcing operating results for the period ended March 31, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). This is a standard earnings release disclosure with the press release furnished as Exhibit 99.1, which is material to investors assessing the company's financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-05-19
Item 2.02
DUOS Technologies Group disclosed financial and operating results for Q1 2026 via a press release issued on May 18, 2026, with discussion by the CEO and CFO on an earnings call. The disclosure includes forward-looking statements on revenue recognition, profitability, and backlog.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-05-19
Item 5.02
The disclosure centers on a new employment agreement with Jamal Haughton, an Executive Vice President, General Counsel & Corporate Secretary, detailing compensatory arrangements including base salary ($825,000), target bonus (160% of base), annual equity grants ($4,000,000 commencing 2027), a top-up award ($656,250), and severance provisions. While the agreement also confirms his continued role, the substantive focus is on the compensation structure and terms, making this an exec_compensation event rather than an appointment.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-19
Item 1.01
The filing discloses a material amendment to a $4.5M revolving credit facility that extends the maturity date and imposes new restrictive covenants requiring refinancing by September 15, 2026 or face a $15,000 failure-to-perform fee and default. While this is a debt covenant modification, the language does not indicate a breach or acceleration of existing obligations—rather, it is a negotiated extension with new conditions. This does not cleanly fit "covenant_breach" (which typically signals a triggering event causing acceleration) but represents a material modification to the company's financing arrangements that would affect investor assessment of liquidity and financial flexibility.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-05-19
Item 1.01
Innovative Industrial Properties entered into material definitive loan agreements totaling $22.9 million ($10.5M MA Loan and $12.4M PA Loan) with indirect subsidiaries, secured by mortgages and guaranteed by the parent company.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This is a clear Item 5.07 disclosure of shareholder vote results from SiteOne's May 13, 2026 Annual Meeting of Stockholders. The filing reports final voting tallies for three proposals: election of directors (William W. Douglas III and Jeri L. Isbell), ratification of Deloitte & Touche LLP as independent auditor, and advisory approval of named executive officer compensation. All three proposals passed with substantial majorities, making this a routine but material governance disclosure.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-05-19
Item 5.02
Mr. Bryan Pechersky, Executive Vice President, General Counsel and Corporate Secretary, notified the Company of his resignation effective June 5, 2026. This is a departure of a senior officer responsible for legal and corporate governance functions. The disclosure explicitly states the resignation was not due to disagreement, but the departure of a named executive in a material role is material to investors assessing management continuity and legal oversight.
View raw filing on EDGAR →
8-K
M&A activity
confidence 96%
filed 2026-05-19
Item 1.01
Kimbell Royalty Partners entered into a Purchase and Sale Agreement to acquire mineral interests, royalty interests, and non-participating royalty interests in oil and gas properties across Texas and New Mexico for approximately $44 million in cash plus 6,929,000 OpCo Common Units and Class B Units, representing a material acquisition of assets with significant proved reserves and production.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-05-19
Item 3.02
Kimbell issued 6,929,000 OpCo Common Units and Class B Units as part of the acquisition consideration, representing an unregistered equity issuance under Section 4(a)(2) exemption that materially dilutes existing ownership.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-05-19
Item 1.01
Exyn Technologies completed its initial public offering on May 18, 2026, raising approximately $19.4 million gross proceeds through the sale of 2,500,000 units at $7.75 per unit pursuant to a definitive underwriting agreement with Lucid as underwriter. The IPO represents a material capital-raising event and transition from private to public company status.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-05-19
Item 3.02
In connection with the IPO closing, the Company issued warrants to purchase 71,875 shares of Common Stock to Lucid as underwriting compensation, relying on the Section 4(a)(2) exemption from registration.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-19
Item 5.03
Upon IPO closing on May 18, 2026, the Company's amended and restated certificate of incorporation and bylaws became effective, establishing the governance framework for the newly public entity.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-05-19
Item 1.01
This disclosure describes entry into material definitive agreements in connection with the issuance of asset-backed securities (Notes) by Ford Credit Floorplan Master Owner Trust A. The issuance of ABS represents a material financing/capital markets transaction that would affect a reasonable investor's assessment of the registrant's capital structure and liquidity. While not a traditional M&A transaction, the securitization structure and entry into multiple transaction documents constitute material capital-raising activity reportable under Item 1.01.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-05-19
Item 1.01
This disclosure describes entry into material definitive agreements in connection with the issuance of asset-backed securities by Ford Credit Floorplan Master Owner Trust A. The structured financing transaction involving securitization of floorplan receivables constitutes a material capital markets activity that would affect investor assessment of the registrant's financing structure and liquidity. While not a traditional M&A transaction, securitization activity is a material financing event that falls within the scope of Item 1.01 material definitive agreements.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-19
Item 8.01
PSB Financial announced the expected closing of a mutual-to-stock conversion and related initial public offering on May 21, 2026, with OTCQB listing to commence May 22, 2026. While this is a significant corporate transformation event affecting the company's ownership structure and public status, it does not fit neatly into the standard M&A taxonomy (ma_activity typically covers acquisitions, dispositions, mergers, or changes of control involving another entity). The conversion and IPO are material to investors but represent a structural reorganization distinct from traditional M&A.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
Juniata Valley Financial Corp. held its Annual Meeting of Shareholders on May 19, 2026, with shareholders voting on three proposals: election of three Class C directors, approval of a non-binding say-on-pay proposal, and approval of the 2026 Incentive Plan. The filing reports the specific vote tallies for each proposal.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Crawford & Company's 2026 Annual Meeting of Shareholders held on May 14, 2026. The filing presents voting results for three matters: (1) election of nine directors, (2) approval of an amendment to the 2016 Omnibus Stock and Incentive Plan fixing the termination date as May 13, 2032, and (3) ratification of KPMG, LLP as independent auditor. All three proposals passed with substantial majorities. Shareholder vote results are material to investors as they confirm governance and compensation plan decisions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-05-19
Item 5.07
BlueLinx held its 2026 Annual Meeting of Stockholders on May 14, 2026, with shareholders voting on director elections, ratification of Ernst & Young LLP as independent auditor, an advisory vote on executive compensation, and approval of an amendment to the 2021 Plan to increase share reserves. Director Mitchell B. Lewis was not re-elected, receiving 2.6M votes for versus 3.3M against, while the other three proposals were approved by shareholders.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-05-19
Item 8.01
The filing discloses adjournment of a stockholder meeting related to a "proposed transaction between TWO and CrossCountry Intermediate Holdco, LLC," which constitutes material M&A activity. Although the disclosure focuses on the procedural adjournment rather than execution of the deal itself, the underlying transaction is a material acquisition or merger that would affect investor assessment of the registrant's strategic direction and financial position.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
Redwood Trust held its Annual Meeting on May 19, 2026, with shareholders voting on four matters: election of eight directors, ratification of Grant Thornton LLP as independent auditor, advisory approval of named executive officer compensation, and approval of an amendment to the 2014 Incentive Award Plan increasing the share reserve by 8,500,000 shares. All four proposals passed with substantial majorities.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-19
Item 3.02
The filing discloses unregistered issuances of equity securities totaling 310,575 shares upon conversion of a convertible note, relying on Section 4(a)(2) exemption. This represents a dilutive capital event where the company issued approximately 10.3% of its outstanding shares (310,575 of 3,028,362 shares) to satisfy debt obligations, which is material to investors assessing ownership dilution and the company's capital structure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Intercontinental Exchange's Annual Meeting of Stockholders held on May 15, 2026. The filing presents voting results for five matters: election of eleven directors, advisory vote on executive compensation, amendments to the Certificate of Incorporation, ratification of Ernst & Young LLP as auditor, and a stockholder proposal on independent board chairman. These are material governance events that affect investor understanding of board composition and corporate oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
Item 5.07 discloses the results of XPO's 2026 annual meeting of stockholders held on May 19, 2026, including voting outcomes for three proposals: (1) election of seven directors, (2) ratification of KPMG LLP as independent auditor, and (3) advisory vote on executive compensation. The detailed vote tallies (votes for, against, abstentions, and broker non-votes) for each proposal are the core disclosure, which is the standard format for shareholder vote results under Item 5.07.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-05-19
Item 1.01
The filing discloses entry into a material definitive agreement (the Famatown Support Agreement) that is explicitly conditioned on consummation of Transocean's acquisition of Valaris Limited. While the agreement itself concerns board nomination rights, the central material event is the acquisition of Valaris, which is referenced as a condition precedent to the nomination right and represents a significant M&A transaction. The agreement's materiality derives from the underlying acquisition activity.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-05-19
Item 1.01
Bank First Corporation entered into an Agreement and Plan of Merger with PSB Holdings, Inc., whereby PSB will merge into BFC at an exchange ratio of 0.3470 BFC shares per PSB share, with closing expected in Q4 2026. The transaction involves the merger of both parent companies and their subsidiary banks and is expected to generate material synergies.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-19
Item 1.01
The Company entered into an underwriting agreement on May 18, 2026, to conduct an underwritten public offering of 3,581,000 shares of Class A common stock plus pre-funded warrants and multiple series of warrants, with net proceeds of approximately $8.9 million. Additionally, a concurrent registered direct offering to directors and officers for 71,607 shares was executed. These are registered equity issuances that will dilute existing shareholders and raise capital, fitting the dilutive_issuance category. The materiality is clear given the substantial number of shares being issued and the capital raised.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-05-19
Item 1.01
The filing discloses the consummation of a material acquisition of a multifamily residential transition loan portfolio by Rithm Property Trust through a Flow Mortgage Loan Purchase and Sale Agreement with Rithm Loan Aggregation Trust. The transaction involves the purchase of mortgage loan assets on a servicing-released basis, which constitutes a material acquisition activity reportable under Item 1.01. The agreement also establishes an ongoing framework for future periodic purchases of similar loan portfolios meeting specified eligibility criteria.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
ONE Group Hospitality held its 2026 Annual Meeting of Stockholders on May 19, 2026, with shareholders voting on four matters: election of three Class I directors (Dimitrios Angelis, James Chambers, Michael Serruya), ratification of Deloitte & Touche as independent auditor, advisory approval of named executive officer compensation, and approval of an amendment to the 2019 Equity Incentive Plan. All proposals received requisite shareholder approval.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-05-19
Item 7.01
This Item 7.01 disclosure centers on Paramount's commencement of tender offers and exchange offers totaling $15.2 billion in principal amount in connection with the proposed acquisition of Warner Bros. Discovery, Inc. The filing explicitly states "The Offers are being conducted in connection with the proposed acquisition (the 'Acquisition') by Paramount of Warner Bros. Discovery, Inc. ('WBD')." The disclosure also covers acquisition financing transactions, deleveraging commitments, and pro forma financial information—all material components of a major M&A transaction. This is a highly material event affecting the total mix of information available to investors regarding a transformative acquisition.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
Bed Bath & Beyond held its Annual Meeting on May 14, 2026, with stockholders voting on six proposals: election of directors, ratification of auditors (KPMG LLP), say-on-pay vote, amendment to increase authorized common shares from 100 million to 200 million, adjournment authority, and amendment and restatement of the 2005 Equity Incentive Plan increasing the share pool by 4,291,000 shares. Detailed vote tallies (For/Against/Abstain/Broker Non-Votes) were disclosed for each proposal.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
NBT Bancorp held its Annual Meeting of Stockholders on May 19, 2026, with shareholders voting on three proposals: election of 12 directors, advisory approval of named executive officer compensation, and ratification of KPMG as independent auditor. All three proposals passed with substantial majorities.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-19
Item 7.01
NBT Bancorp's Board of Directors approved a quarterly cash dividend of $0.37 per share, with specified payment and record dates, representing a material capital allocation decision for shareholders.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This Item 5.07 disclosure reports the results of CME Group's 2026 Annual Meeting of Shareholders held on May 14, 2026, including voting outcomes on director elections (14 equity directors), auditor ratification (Ernst & Young LLP), and advisory compensation approval. The filing presents detailed vote tallies (FOR, AGAINST, ABSTAIN) for each proposal, which is the core content of shareholder vote result disclosures required under Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
NOVAGOLD held its 2026 Annual Meeting of Shareholders on May 14, 2026, with voting results on seven proposals including director elections, auditor appointment, stock plan amendments, and executive compensation resolutions. The filing reports the complete voting tallies for all proposals, reflecting shareholder approval of governance and equity plan matters.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This is a clear disclosure of shareholder vote results from ServisFirst Bancshares' 2026 Annual Meeting held on May 18, 2026. The filing reports final voting tallies for three matters: election of seven directors (all elected), advisory vote on named executive officer compensation (approved), and ratification of Forvis Mazars, LLP as independent auditor (approved). The detailed vote counts for each director and proposal are provided, matching the Item 5.07 requirement for shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-19
Item 8.01
The filing discloses the appointment of Keith D. Rose, M.D. as Chief Medical Officer, effective May 1, 2026. This is a material executive appointment to a senior leadership position. Dr. Rose's extensive background in medical affairs and clinical leadership across major pharmaceutical companies (Novocure, Ipsen, Jazz Pharmaceuticals, Indivior) demonstrates the significance of this hire to the Company's medical and clinical strategy.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-05-19
The filing discloses fiscal 2026 and fiscal fourth quarter financial results announced via press release on May 19, 2026, under Item 2.02 (Results of Operations and Financial Condition). Item 7.01 confirms the earnings announcement and notes a scheduled earnings call. The press release is furnished as Exhibit 99.1, which is the standard format for earnings disclosures in 8-K filings.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-05-19
Item 2.02
Item 2.02 disclosure of quarterly and fiscal year financial results for the period ended March 31, 2026, with an earnings press release furnished as Exhibit 99.1. This is a standard earnings announcement that would materially affect investor assessment of the company's financial performance.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-19
Item 8.01
Korro Bio announced the addition of KRRO-111 for Alpha-1 Antitrypsin Deficiency to its pipeline, disclosed via press release and updated investor presentation. While this represents a material pipeline expansion for a clinical-stage biotech company that would affect investor assessment of the company's development strategy and future prospects, it does not fit neatly into the more specific event categories (not an earnings release, M&A activity, impairment, or other defined event types). This is best classified as other_material.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-19
Item 8.01
FMC announced a proposed $750 million private offering of senior secured notes due 2031 to refinance existing debt and for general corporate purposes. While this is a material financing event affecting the company's capital structure and liquidity, it does not fit cleanly into the standard taxonomy categories (not an M&A activity, not a dilutive equity issuance, not a covenant breach). The disclosure centers on the announcement of a debt offering rather than completion of a transaction, making "other_material" the most appropriate classification for this significant financing announcement.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-05-19
Item 5.02
The filing discloses multiple executive appointments on May 18, 2026: Dr. Miralles as President and Head of R&D (with $600,000 base salary, 45% bonus target, and substantial equity grants of 232,500 options and 77,500 RSUs), and Dr. Aslan as principal financial and accounting officer. While the section also includes departures (Dr. Miralles from the Board, Dr. Aslan from President, and Thad Huston as CFO), the principal disclosed actions center on the appointments of these executives to new roles with defined compensation packages, making exec_appointment the most salient classification.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-05-19
Item 8.01
The Company disclosed a private offering of Convertible Senior Notes due 2032 to qualified institutional buyers pursuant to Rule 144A. Convertible notes are dilutive securities that may result in issuance of Class A common stock upon conversion, making this a dilutive issuance material to investors assessing capital structure and potential equity dilution.
View raw filing on EDGAR →
8-K
Other material
confidence 74%
filed 2026-05-19
Item 8.01
Relay Therapeutics announced initial Phase 2 clinical trial data from the ReInspire study of zovegalisib in vascular anomalies, reporting a 60% volumetric response rate in 20 evaluable patients, 89% clinical improvement in patient-reported outcomes (IGIC), and low Grade 3+ adverse event rates at lower doses.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-19
Item 2.03
This Item 2.03 disclosure reports the creation of direct financial obligations through the issuance of consolidated obligations (bonds and discount notes) by the Federal Home Loan Bank of Pittsburgh. While the filing explicitly states "consolidated obligations issuance is material to the FHLBank," the disclosure is primarily informational and regulatory in nature—describing the mechanics of consolidated obligation issuance, the joint and several liability structure, and referencing Schedule A for specific debt instruments. This does not fit cleanly into covenant_breach (no violation alleged) or the more specific debt-related categories, making other_material the most appropriate classification for this regulatory debt disclosure.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-05-19
Item 2.02
The filing discloses a press release announcing "expected quarterly revenue results for its fiscal 2026 year ended March 31, 2026," which is a classic earnings release disclosure under Item 2.02. The press release is furnished as Exhibit 99.1, a standard format for earnings announcements. This is material to investors as it provides financial performance data for the fiscal year.
View raw filing on EDGAR →
8-K
M&A activity
confidence 96%
filed 2026-05-19
Item 2.01
Mister Car Wash, Inc. was acquired in a merger at $7.00 per share in cash, with the transaction consummated on May 19, 2026. The merger was funded by a $900 million senior secured first lien incremental term loan facility, and resulted in the conversion of all common stock into cash consideration, termination of equity plans, and immediate delisting from NASDAQ.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-05-19
Item 3.01
On May 19, 2026, Mister Car Wash notified NASDAQ of the merger consummation and requested delisting of its common stock (ticker 'MCW') via Form 25 filing. Trading was suspended prior to market open, and the company intends to file Form 15 to deregister and terminate reporting obligations.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-19
Item 8.01
Kennametal announced a cash tender offer for its 4.625% Senior Notes due 2028 and a concurrent underwritten public offering of senior notes. While this involves debt refinancing activity, it does not fit cleanly into the M&A taxonomy (which focuses on acquisitions, dispositions, mergers, or changes of control). The tender offer and new debt issuance are material financing transactions that would affect investor assessment of the company's capital structure and liquidity, but lack a more specific event classification.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-05-19
Item 7.01
The Trust disclosed receipt of a Schedule 13D filed by SoftVest relating to a "proposed business combination involving the Trust." The disclosure explicitly references a potential merger or change-of-control transaction, with anticipated Form S-4 filing and unitholder meeting. This constitutes material M&A activity under Item 1.01 or 2.01 framework, even though disclosed via Item 7.01 (Regulation FD).
View raw filing on EDGAR →